Haemophilus somnus activation of brain endothelial cells: Potential role for local cytokine production and thrombosis in central nervous system (CNS) infection

Thrombosis and Haemostasis

Volumn 98, Issue 4, 2007, Pages 823-830

  Behling Kelly, Erica ^a   Kim, Kwang S ^b   Czuprynski, Charles J ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brain; Endothelial; Haemophilus; Infection; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; THROMBOMODULIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING DISORDER; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HISTOPHILUS SOMNI; IN VITRO STUDY; MENINGOENCEPHALITIS; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; CATTLE; CENTRAL NERVOUS SYSTEM INFECTIONS; COAGULANTS; CYTOKINES; ENDOTHELIAL CELLS; FIBRIN; HAEMOPHILUS SOMNUS; INFLAMMATION; MODELS, BIOLOGICAL; PROTEIN C; THROMBOPLASTIN; THROMBOSIS;

EID: 35048891928     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-11-0665     Document Type: Article

References (51)

1. Janzen FW. The Haemophilus somnus disease complex (hemophilosis): a review. Can Vet J 1989; 30: 816-822.
2. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
3. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
4. Myers DD, Wakefield TW. Inflammation-dependent thrombosis. Front Biosci 2005; 10: 2750-2757.
5. Strukova S. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci 2006; 11: 59-80.
6. Schnittler HJ, Preissner KT. Vascular endothelium and infectious diseases: trick and treat. Thromb Haemost 2005; 94: 238-239.
7. Bielaszewska M, Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost 2005; 94: 312-318.
8. Stins MF, Prasadarao NV, Zhou J, et al. Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: development of an immortalized cell line to study pathophysiology of CNS disease. In Vitro Cell Dev Biol Anim 1997; 33: 243-247.
9. Hezi-Yamit A, Wong PW, Bien-Ly N, et al. Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades. Proc Natl Acad Sci USA 2005; 102: 12077-12082.
10. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114: 321-327.
11. Lopes-Bezerra LM, Filler SG. Endothelial cells, tissue factor and infectious diseases. Braz J Med Biol Res 2003; 36: 987-991.
12. Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 300: 729-735.
13. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456-461.
14. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29 S48-51; discussion 51-52.
15. Pathan N, Faust SN, Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 2003; 88: 601-607.
16. Brandtzaeg P, Bjerre A, Ovstebo R, et al. Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7: 401-420.
17. Heyderman RS, Klein NJ, Daramola OA, et al. Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium. Microb Pathog 1997; 22: 265-274.
18. Mirlashari MR, Hoiby EA, Holst J, et al. Outer membrane vesicles from Neisseria meningitidis: effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes. Thromb Res 2001; 102: 375-380.
19. Czuprynski CJ, Leite F, Sylte M, et al. Complexities of the pathogenesis of Mannheimia haemolytica and Haemophilus somnus infections: challenges and potential opportunities for prevention? Anim Health Res Rev 2004; 5: 277-282.
20. Sylte MJ, Corbeil LB, Inzana TJ, et al. Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro. Infect Immun 2001; 69: 1650-1660.
21. Bombeli T, Karsan A, Tait JF, et al. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-2442.
22. Kuckleburg CJ, Elswaifi SF, Inzana TJ, et al. Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation. Infect Immun 2007; 75: 1045-1049
23. Thompson KG, Little PB. Effect of Haemophilus somnus on bovine endothelial cell in organ culture. Am J Vet Res 1981; 42: 748-754.
24. Behling-Kelly E, McClenahan O, Kim KS, et al. Viable Haemophilus somnus induces myosin light-chain kinase-dependent decrease in brain endothelial monolayer resistance. Infect Immun 2007; 75: 4572-4581.
25. Behling-Kelly E, Vonderheid H, Kim KS, et al. Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells. Infect Immun 2006; 74: 5311-5318.
26. Taha MK. Neisseria meningitidis induces the expression of the TNF-alpha gene in endothelial cells. Cytokine 2000; 12: 21-25.
27. Verma S, Nakaoke R, Dohgu S, et al. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav Immun 2006; 20: 449-455.
28. Liu Y, Pelekanakis K, Woolkalis MJ. Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: Regulation through c-Fos and c-Jun. J Biol Chem 2004; 279: 36142-36147.
29. Nawroth PP, Handley DA, Esmon CT, et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460-3464.
30. Stern DM, Bank I, Nawroth PP, et al. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985; 162: 1223-1235.
31. Emerson TE, Jr., Lindsey DC, Jesmok GJ, et al. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ Shock 1992; 38: 75-84.
32. Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 1233-1239.
33. Wada H, Tanigawa M, Wakita Y, et al. Increased plasma level of interleukin-6 in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1993; 4: 583-590.
34. van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-1259.
35. Derhaschnig U, Bergmair D, Marsik C, et al. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med 2004; 32: 1136-1140.
36. Welty-Wolf KE, Carraway MS, Ortel TL, et al. Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol 2006; 290: L21-31.
37. Carraway MS, Welty-Wolf KE, Miller DL, et al. Blockade of tissue factor: Treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167: 1200-1209.
38. Maris NA, de Vos AF, Bresser P, et al. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 2005; 93: 1036-1040.
39. de Waard V, Hansen HR, Spronk HH, et al. Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost 2006; 95: 348-353.
40. Carraway MS, Welty-WolfKE, Miller DL, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167: 200-1209.
41. Creasey AA, Chang AC, Feigen L, et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91: 2850-2860.
42. Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006; 32: 33-39.
43. Henriksson CE, Hellum M, Landsverk KS, et al. Flow cytometry-sorted non-viable endotoxin-treated human monocytes are strongly procoagulant. Thromb Haemost 2006; 96: 29-37.
44. Henriksson CE, Klingenberg O, Hellum M, et al. Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death. Thromb Res 2007; 119: 621-630.
45. Henriksson CE, Klingenberg O, Ovstebo R, et al. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis. Thromb Haemost 2005; 94: 1236-1244.
46. Tiruppathi C, Naqvi T, Sandoval R, et al. Synergistic effects of tumor necrosis factor-{alpha} and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol 2001; 281(4): L958-968.
47. Esmon CT. The protein C pathway. Chest 2003; 124: 26S-32.
48. Dhainaut JF, Yan SB, Margolis BD, et al. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients: with severe sepsis. Thromb Haemost 2003; 90: 642-653.
49. Lentz S, Tsiang M, Sadler J. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood 1991; 77: 542-550.
50. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73: 159-165.
51. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001; 345: 408-416.